Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Elisa Gotti"'
Autor:
Giuseppe Gritti, Silvia Ferrari, Federico Lussana, Anna Maria Barbui, Francesco Landi, Monica Rondi, Alessandro Putelli, Francesco Ballardini, Giulia Quaresmini, Muriel Paganessi, Chiara Pavoni, Arianna Ghirardi, Elisa Gotti, Chiara Capelli, Josée Golay, Martino Introna, Alessandro Rambaldi
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/f762c188dbf54df5a16ff6071725f9ad
Autor:
Silvia Zaninelli, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Francesca D’Autilia, Rut Valgardsdottir, Elisa Gotti, Alessandro Rambaldi, Josée Golay, Martino Introna
Publikováno v:
Antibodies, Vol 13, Iss 3, p 71 (2024)
Strategies to increase the anti-tumor efficacy of cytokine-induced killer cells (CIKs) include genetic modification with chimeric antigen receptors (CARs) or the addition of soluble T-cell engaging bispecific antibodies (BsAbs). Here, CIKs were modif
Externí odkaz:
https://doaj.org/article/2e46ffc25a0e4747b6c5221b2f34f8e8
Autor:
Elisa Gotti, Sarah Tettamanti, Silvia Zaninelli, Carolina Cuofano, Irene Cattaneo, Maria Caterina Rotiroti, Sabrina Cribioli, Rachele Alzani, Alessandro Rambaldi, Martino Introna, Josée Golay
Publikováno v:
Cytotherapy. 24:334-343
Our center performs experimental clinical studies with advanced therapy medicinal products (ATMPs) based on polyclonal T cells, all of which are currently expanded in standard T-flasks. Given the need to increase the efficiency and safety of large-sc
Autor:
Giuseppe Gritti, Federico Lussana, Silvia Ferrari, Anna Maria Barbui, Francesco Landi, Giulia Quaresmini, Gianmaria Borleri, Muriel Paganessi, Chiara Pavoni, Elisa Gotti, Chiara Capelli, Josee Golay, Martino Introna, Alessandro Rambaldi
Publikováno v:
Blood. 140:10325-10326
Autor:
Federico Lussana, Chiara Francesca Magnani, Giuseppe Gaipa, Stefania Galimberti, Giuseppe Gritti, Daniela Belotti, Sara Napolitano, Chiara Buracchi, Gian Maria Borleri, Benedetta Rambaldi, Giuliana Rizzuto, Anna Grassi, Muriel Paganessi, Silvia Ferrari, Sarah Tettamanti, Giovanni Gazzaniga, Chiara Capelli, Elisa Gotti, Martino Introna, Adriana Balduzzi, Maria Grazia Valsecchi, Giuseppe Dastoli, Alessandro Rambaldi, Andrea Biondi
Publikováno v:
Blood. 140:4568-4569
Autor:
Benedetta Rambaldi, Stefania Galimberti, Giuliana Rizzuto, Chiara Francesca Magnani, Chiara Buracchi, Giulia Risca, Martina Paredi, Daniela Belotti, Alex Moretti, Marianna Ponzo, Sarah Tettamanti, Gian Maria Borleri, Cristian Meli, Muriel Paganessi, Silvia Zaninelli, Elisa Gotti, Chiara Capelli, Martino Introna, Federico Lussana, Giuseppe Gritti, Silvia Ferrari, Anna Grassi, Sara Napolitano, Adriana Balduzzi, Maria Grazia Valsecchi, Giuseppe Dastoli, Alessandro Rambaldi, Andrea Biondi, Giuseppe Gaipa
Publikováno v:
Blood. 140:10339-10340
Autor:
Mara Magri, Chiara Capelli, Marco Passera, Elisa Gotti, Josée Golay, Francesca Vailati, Gianmaria Borleri, Martino Introna, Alessandro Rambaldi, Claudio Farina, Olga Pedrini
Publikováno v:
Cytotherapy. 20:262-270
Background We analyzed the results of routine sterility testing performed in our center over the last 10 years, in the context both hematopoietic stem cell transplantation (HSCT) and Advanced Therapeutic Medicinal Products (ATMPs). Methods For steril
Publikováno v:
HemaSphere. 3:170-171
Autor:
Benedetta Mazzanti, Riccardo Saccardi, Sabrina Cribioli, Josée Golay, Martino Introna, Elisa Gotti, Simona Martinelli, Rachele Alzani, Clara Albanese, Alessandro Rambaldi, Bruna Pasini
Publikováno v:
Cytotherapy. 20(8)
Background Cytokine-induced killer cells (CIKs) are an advanced therapeutic medicinal product (ATMP) that has shown therapeutic activity in clinical trials but needs optimization. We developed a novel strategy using CIKs from banked cryopreserved cor
Autor:
Federica Delaini, Paolo Perseghin, Giuseppe Gaipa, Maria Luisa Ferrari, Alessandro Rambaldi, Alessandra Algarotti, Matteo Parma, Chiara Pavoni, Benedetta Cabiati, Elisa Gotti, Ettore Biagi, Martino Introna, Elisabetta Todisco, Sara Deola, Josée Golay, Rut Valgardsdottir, Sara Napolitano, Daniela Belotti, Adriana Balduzzi, Federico Lussana, Giusy Sgroi, Caterina Micò, Andrea Biondi, Irene Cavattoni, Emanuela Marrocco, Attilio Rovelli, Anna De Grassi
Seventy-four patients who relapsed after allogeneic stem cell transplantation were enrolled in a phase IIA study and treated with the sequential infusion of donor lymphocyte infusion (DLI) followed by cytokine-induced killer (CIK) cells. Seventy-thre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b64628e5d441bea0947f04145b6c9b
http://hdl.handle.net/10281/221928
http://hdl.handle.net/10281/221928